• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BIOMERIEUX SA CEFOTAXIME CTL 32 US S30

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BIOMERIEUX SA CEFOTAXIME CTL 32 US S30 Back to Search Results
Catalog Number 412280
Device Problem Incorrect Or Inadequate Test Results (2456)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Type  malfunction  
Manufacturer Narrative
Device not returned to manufacturer.
 
Event Description
A customer called with out of range results for qc testing using etest cefotaxime ctl 32 us s30, (b)(4), lot 1004047910.Quality control testing for pseudomonas aeruginosa 27853 were out of range (high) and e.Coli 25922 was acceptable.Additional set-up and testing performed with the same results.Product from a different lot are being sent to the customer for use.An internal investigation has been launched.There was no reported death or serious injury associated with the referenced event.
 
Manufacturer Narrative
This report was initially submitted following notification that a customer in the united states reported pseudomonas aeruginosa atcc® 27853 tm out-of-range-high (mic >=32) in association with etest® cefotaxime ctl 32.Internal investigation was conducted.Etest® cefotaxime ctl 32 is only recommended for streptococcus and fastidious strains.Etest® cefotaxime ctl 32 is not adapted for pseudomonas aeruginosa.This is why pseudomonas aeruginosa atcc® 27853 tm is not recommended for quality control testing against this product.Instructions for use supplementary insert us 15221 states to "please consult the footnotes in the latest clsi tables for further comments and clarification.Interpretive criteria may be different." in clsi, there are no break points for pseudomonas aeruginosa.The etest® cefotaxime ctl 32 product is performing in accordance to performance claims.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CEFOTAXIME CTL 32 US S30
Type of Device
CEFOTAXIME CTL 32 US S30
Manufacturer (Section D)
BIOMERIEUX SA
chemin de l orme
marcy l etoile, rhone 69280
FR  69280
Manufacturer (Section G)
BIOMERIEUX SA
chemin de l orme
marcy l etoile, rhone 69280
FR   69280
Manufacturer Contact
ryan lemelle
595 anglum road
hazelwood, MO 63042
3147318582
MDR Report Key5083567
MDR Text Key26309538
Report Number3002769706-2015-00087
Device Sequence Number1
Product Code JWY
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K981137
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type health professional,user faci
Reporter Occupation Health Professional
Report Date 07/21/2015
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date06/01/2017
Device Catalogue Number412280
Device Lot Number1004047910
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received Not provided
Initial Date FDA Received09/17/2015
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
-
-